Metraipolis › archive › dc_41b7f9c58fdb

Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis — Europe PMC PMID:41028859

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41028859
DOI
10.1038/s41598-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-09T16:50:11.254Z
SHA-256 of the archived text
5ab5336307fc99f16c001d730e26af4980775a16d38c252ef18d6b50302377c0
Stable URL of this page
https://metraipolis.com/documento/dc_41b7f9c58fdb

How to cite

Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis — Europe PMC PMID:41028859 — Europe PMC (en), https://europepmc.org/article/MED/41028859 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41b7f9c58fdb (Metraipolis archive dc_41b7f9c58fdb, sha256 5ab5336307fc99f16c001d730e26af4980775a16d38c252ef18d6b50302377c0)
BibTeX
@misc{dc41b7f9c58fdb,
  title = {Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis — Europe PMC PMID:41028859},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41028859},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41b7f9c58fdb; sha256 5ab5336307fc99f16c001d730e26af4980775a16d38c252ef18d6b50302377c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41028859. Agents can read the archived copy with the MCP tool read_document.